{"id":"W4393989206","doi":"10.1158/1538-7445.am2024-ct265","title":"Abstract CT265: Trastuzumab emtansine in patients (pts) with <i>HER2</i> mutation-positive <i>(HER2</i>mut<i>)</i> tumors: TAPISTRY study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Trastuzumab; Trastuzumab emtansine; Medicine; Mutation; Internal medicine; Oncology; Cancer; Cancer research; Breast cancer; Biology; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008792668,0.0006966136,0.000700599,0.0002059316,0.000244783,0.0006973562,0.0003393177,0.0005044436,0.003756813],"category_scores_gemma":[0.000611609,0.0002239064,0.0008279707,0.0003320999,0.0003414583,0.0005261909,0.0003232444,0.001535099,0.0008190149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007134254,"about_ca_system_score_gemma":0.0009291482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008999003,"about_ca_topic_score_gemma":0.00242108,"domain_scores_codex":[0.9997655,0.0001051295,0.00001674074,0.00004767023,0.00003350749,0.0000315191],"domain_scores_gemma":[0.9995874,0.0000529809,0.0001140829,0.0000257602,0.00003742465,0.0001824279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8084872,0.0132684,0.04950691,0.0009116877,0.001824764,0.000478665,0.0001987085,0.002549523,0.03408365,0.0003946893,0.01652088,0.071775],"study_design_scores_gemma":[0.4490288,0.3775327,0.1391313,0.0002027361,0.003011771,0.00110197,0.0001609201,0.002459576,0.01014076,0.0004063447,0.01674986,0.0000733242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890593,0.001685554,0.0002894704,0.0004570149,0.00006931505,0.0006813798,0.004013777,0.00005436421,0.003689683],"genre_scores_gemma":[0.9900157,0.0009227418,0.0003635882,0.0005877308,0.0001306696,0.0003813706,0.005378623,0.00001752458,0.002202059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003756813,"threshold_uncertainty_score":0.01256782,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04878923140411118,"score_gpt":0.4222173071015696,"score_spread":0.3734280756974585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}